Patents Assigned to Cornell Research Foundation
-
Patent number: 8716460Abstract: One aspect of the present invention relates to isolated nucleic acid molecules encoding avirulence proteins or polypeptides of Pseudomonas syringae pv. syringae DC 3000, or nucleic acid molecules which are complementary thereto. Expression vectors, host cells, and transgenic plants which include the DNA molecules of the present invention are also disclosed. Another aspect relates to the isolated proteins or polypeptides and compositions containing the same. The various nucleic acid molecules and proteins of the present invention can be used to impart disease resistance to a plant, make a plant hypersusceptible to colonization by nonpathogenic bacteria, modify a metabolic pathway in a cell, cause eukaryotic cell death and treat a cancerous condition, as well as inhibit programmed cell death.Type: GrantFiled: December 27, 2006Date of Patent: May 6, 2014Assignees: Kansas State University Research Foundation, The Board of Regents of the University of Nebraska, Cornell Research Foundation, Inc., The United States of America as Represented by the Secretary of AgricultureInventors: James R. Alfano, Alan Collmer, Samuel W. Cartinhour, David J. Schneider, Xiaoyan Tang
-
Publication number: 20140117586Abstract: The present invention relates to an article fabrication system having a plurality of material deposition tools containing one or more materials useful in fabricating the article, and a material deposition device having a tool interface for receiving one of the material deposition tools. A system controller is operably connected to the material deposition device to control operation of the material deposition device. Also disclosed is a method of fabricating an article using the system of the invention and a method of fabricating a living three-dimensional structure.Type: ApplicationFiled: January 2, 2014Publication date: May 1, 2014Applicant: CORNELL RESEARCH FOUNDATIONInventors: Lawrence Bonassar, Hod Lipson, Daniel L. Cohen, Evan Malone
-
Patent number: 8703928Abstract: The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.Type: GrantFiled: September 9, 2011Date of Patent: April 22, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Francis Barany, George Barany, Robert P. Hammer, Maria Kempe, Herman Blok, Monib Zirvi
-
Publication number: 20140106431Abstract: The present invention is directed to a mutant thermostable ligase having substantially higher fidelity than either T4 ligase or Thermus thermophilus ligase. The ligase of the present invention is a mutant of a wild-type thermostable ligase having a histidine adjacent a KXDG motif, where the mutant thermostable ligase has a mutation in its amino sequence where the histidine adjacent the KXDG motif in the wild-type thermostable ligase is replaced with an arginine, and wherein X is any amino acid. The DNA molecule encoding this enzyme as well as expression systems and host cells containing it are also disclosed. The thermostable ligase of the present invention is useful in carrying out a ligase detection reaction process and a ligase chain reaction process.Type: ApplicationFiled: September 16, 2013Publication date: April 17, 2014Applicant: Cornell Research Foundation, Inc.Inventors: Francis BARANY, Weiguo CAO, Jie TONG
-
Publication number: 20140100135Abstract: The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.Type: ApplicationFiled: December 9, 2013Publication date: April 10, 2014Applicant: Cornell Research Foundation, Inc.Inventors: Francis BARANY, George BARANY, Robert P. HAMMER, Maria KEMPE, Herman BLOK, Monib ZIRVI
-
Patent number: 8663625Abstract: The present invention relates to a monolithic biomaterial. The monolithic biomaterial has a primary network of convective flow, microfluidic channels that are embedded in a substrate, where the substrate is diffusively permeable to aqueous solutes. The present invention also relates to a method of making the monolithic biomaterial, as well as methods of using the monolithic biomaterial to facilitate healing of a cutaneous wound of a mammalian subject and of regulating cells.Type: GrantFiled: October 17, 2005Date of Patent: March 4, 2014Assignee: Cornell Research FoundationInventors: Abraham D. Stroock, Mario Cabodi, Lawrence Bonassar
-
Publication number: 20140045260Abstract: The present invention relates to adenovirus E4ORF1 gene and to endothelial cells engineered to express the E4ORF1 gene. The present invention also relates to uses of the E4ORF1 gene, and cells expressing the E4ORF1 gene, and to compositions comprising the E4ORF1 gene, or comprising cells expressing the E4ORF1 gene.Type: ApplicationFiled: May 20, 2013Publication date: February 13, 2014Applicant: Cornell Research Foundation, Inc.Inventors: Shahin RAFII, Fan ZHANG, Marco SEANDEL
-
Patent number: 8642332Abstract: The present invention is directed to a method of producing neuronal progenitor cells by providing an isolated population of progenitor cells from human brain white matter and permitting the isolated population of cells to differentiate to neuronal progenitor cells. Alternatively, neuronal progenitor cells can be produced by providing an isolated population of glial progenitor cells and permitting the isolated population of glial progenitor cells to differentiate to neuronal progenitor cells.Type: GrantFiled: March 4, 2004Date of Patent: February 4, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Steven A. Goldman, Neeta Singh Roy
-
Patent number: 8642269Abstract: The present invention relates to a method for identifying a target nucleotide sequence. This method involves forming a ligation product on a target nucleotide sequence in a ligation detection reaction mixture, amplifying the ligation product to form an amplified ligation product in a polymerase chain reaction (PCR) mixture, detecting the amplified ligation product, and identifying the target nucleotide sequence. Such coupling of the ligase detection reaction and the polymerase chain reaction permits multiplex detection of nucleic acid sequence difference.Type: GrantFiled: July 6, 2012Date of Patent: February 4, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Francis Barany, Matthew Lubin, George Barany, Robert P. Hammer, Phillip Belgrader
-
Patent number: 8636938Abstract: The present invention relates to an article fabrication system having a plurality of material deposition tools containing one or more materials useful in fabricating the article, and a material deposition device having a tool interface for receiving one of the material deposition tools. A system controller is operably connected to the material deposition device to control operation of the material deposition device. Also disclosed is a method of fabricating an article using the system of the invention and a method of fabricating a living three-dimensional structure.Type: GrantFiled: March 21, 2011Date of Patent: January 28, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Lawrence Bonassar, Hod Lipson, Daniel L. Cohen, Evan Malone
-
Patent number: 8633787Abstract: A microelectromechanical structure (MEMS) device includes a secondary MEMS element displaceably coupled to a substrate. A primary MEMS element is displaceably coupled to the secondary MEMS element and has a resonant frequency substantially equal to the secondary MEMS element and has a much larger displacement than the secondary MEMS element.Type: GrantFiled: September 21, 2007Date of Patent: January 21, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Shahyaan Desai, Anil N. Netravali, Michael O. Thompson
-
Patent number: 8624016Abstract: The present invention describes a method for identifying one or more of a plurality of sequences differing by one or more single base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences. The method includes a ligation phase, a capture phase, and a detection phase. The ligation phase utilizes a ligation detection reaction between one oligonucleotide probe, which has a target sequence-specific portion and an addressable array-specific portion, and a second oligonucleotide probe, having a target sequence-specific portion and a detectable label. After the ligation phase, the capture phase is carried out by hybridizing the ligated oligonucleotide probes to a solid support with an array of immobilized capture oligonucleotides at least some of which are complementary to the addressable array-specific portion. Following completion of the capture phase, a detection phase is carried out to detect the labels of ligated oligonucleotide probes hybridized to the solid support.Type: GrantFiled: June 11, 2012Date of Patent: January 7, 2014Assignee: Cornell Research Foundation, Inc.Inventors: Francis Barany, George Barany, Robert P. Hammer, Maria Kempe, Herman Blok, Monib Zirvi
-
Patent number: 8618271Abstract: The present invention relates to an isolated DNA molecule encoding a fagopyritol synthase. A method for producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor is also described. The method includes providing a fagopyritol synthase, providing a substrate comprising a galactosyl donor and a galactosyl acceptor, and combining the fagopyritol synthase with the substrate under conditions effective produce a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor.Type: GrantFiled: May 21, 2010Date of Patent: December 31, 2013Assignee: Cornell Research Foundation, Inc.Inventors: Ralph L. Obendorf, Ueda Takashi
-
Patent number: 8618061Abstract: The invention provides a method for reducing oxidative damage in a mammal, a removed organ, or a cell in need thereof. The method comprises administering an effective amount of an aromatic cationic peptide. The aromatic cationic peptide has (a) at least one net positive charge; (b) a minimum of three amino acids; (c) a maximum of about twenty amino acids, (d) a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; (e) a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 3a or 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1; and (f) at least one tyrosine or tryptophan amino acid.Type: GrantFiled: July 26, 2010Date of Patent: December 31, 2013Assignee: Cornell Research Foundation, Inc.Inventor: Hazel Szeto
-
Publication number: 20130345072Abstract: The present invention is directed to a method of designing a plurality of capture oligonucleotide probes for use on a support to which complementary oligonucleotide probes will hybridize with little mismatch, where the plural capture oligonucleotide probes have melting temperatures within a narrow range. The first step of the method involves providing a first set of a plurality of tetramers of four nucleotides linked together, where (1) each tetramer within the set differs from all other tetramers in the set by at least two nucleotide bases, (2) no two tetramers within a set are complementary to one another, (3) no tetramers within a set are palindromic or dinucleotide repeats, and (4) no tetramer within a set has one or less or three or more G or C nucleotides. Groups of 2 to 4 of the tetramers from the first set are linked together to form a collection of multimer units.Type: ApplicationFiled: July 22, 2013Publication date: December 26, 2013Applicant: Cornell Research Foundation, Inc.Inventors: Francis Barany, Monib Zirvi, Norman P. Gerry, Reyna Favis, Richard Kliman
-
Publication number: 20130327742Abstract: Nanofibers are formed using electrospray deposition from microfluidic source. The source is brought close to a surface, and scanned in one embodiment to form oriented or patterned fibers. In one embodiment, the surface has features, such as trenches on a silicon wafer. In further embodiments, the surface is rotated to form patterned nanofibers, such as polymer nanofibers. The nanofibers may be used as a mask to create features, and as a sacrificial layer to create nanochannels.Type: ApplicationFiled: April 8, 2013Publication date: December 12, 2013Applicant: Cornell Research Foundation, Inc.Inventor: Cornell Research Foundation, Inc.
-
Patent number: 8603971Abstract: The invention provides a method for treating one or more complications of diabetes in a mammal. The method comprises administering to a mammal in need thereof an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1.Type: GrantFiled: August 4, 2010Date of Patent: December 10, 2013Assignee: Cornell Research Foundation, Inc.Inventors: Hazel H. Szeto, Shaoyi Liu, Sunghee Cho
-
Patent number: 8603763Abstract: The present invention relates to a method of determining the presence of a retinoblastoma protein (Rb)-mediated cancerous or pre-cancerous condition in a sample of fixed cells that involves exposing the sample to an antibody that recognizes phosphorylation of serine on the retinoblastoma protein (pS-Rb), and identifying cells in the sample that are recognized by the antibody to pS-Rb, where the recognition of pS-Rb in the sample determines the presence of an Rb-mediated cancerous or pre-cancerous condition. The method also involves identifying the presence of specific cell cycle markers and positive and negative cell cycle regulators to assess the stage of disease progression in a cancer patient having an (Rb)-mediated cancer. The present invention also relates to methods of assessing the efficacy of cancer therapy for an Rb-mediated cancer, determining the mechanism of cell cycle progression in an Rb-mediated cancer, and identifying cells predisposed to developing an Rb-mediated cancerous condition.Type: GrantFiled: April 8, 2005Date of Patent: December 10, 2013Assignee: Cornell Research Foundation, Inc.Inventors: Selina Chen-Kiang, Scott A. Ely, Maurizio Di Liberto
-
Publication number: 20130326736Abstract: Methods of inhibiting plant parasitic nematodes, methods of obtaining transgenic plants useful for inhibiting such nematodes, and transgenic plants that are resistant to plant parasitic nematodes through inhibition of plant nematode CLE peptide receptor genes are provided. Methods for expressing genes at plant parasitic nematode feeding sites with plant nematode CLE peptide receptor gene promoters are also provided, along with nematode CLE peptide receptor gene promoters that are useful for expressing genes in nematode feeding sites as well as transgenic plants and nematode resistant transgenic plants comprising the promoters.Type: ApplicationFiled: July 13, 2011Publication date: December 5, 2013Applicants: THE CURATORS OF THE UNIVERSITY OF MISSOURI, CORNELL RESEARCH FOUNDATION, INC., The United States of America, as represented by the Secretary of Agriculture, Iowa State University Research Foundation, Inc., University of Georgia Research Foundation, Inc., North Carolina State UniversityInventors: Melissa G. Mitchum, Amy Replogle, Jianying Wang, Xiaohong Wang, Shiyan Chen, Ping Lang, Eric L. Davis, Thomas J. Baum, Richard S. Hussey
-
Patent number: 8597891Abstract: The present invention relates to a method for identifying a target nucleotide sequence. This method involves forming a ligation product on a target nucleotide sequence in a ligation detection reaction mixture, amplifying the ligation product to form an amplified ligation product in a polymerase chain reaction (PCR) mixture, detecting the amplified ligation product, and identifying the target nucleotide sequence. Such coupling of the ligase detection reaction and the polymerase chain reaction permits multiplex detection of nucleic acid sequence difference.Type: GrantFiled: July 6, 2012Date of Patent: December 3, 2013Assignee: Cornell Research Foundation, Inc.Inventors: Francis Barany, Matthew Lubin, George Barany, Robert P. Hammer